Related Experiment Video
Updated: Mar 3, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Ameliorative Effect of VE, IGF-I, and hCG on the Fluoride-Induced Testosterone Release Suppression in Mice Leydig
Yuxiang Yu1, Yongli Han1, Ruiyan Niu1,2
1College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi, 030801, People's Republic of China.
Abstract:
Excessive consumption of fluoride (F) through drinking, eating, and/or environmental contaminants induces chronic toxicity known as fluorosis. Our previous research has shown that fluorosis was associated with male reproductive disorders. The current study is designed to explain the protective effect of vitamin E (VE), insulin-like growth factor-I (IGF-I), and human chorionic gonadotropin (hCG) against natrium fluoride (NaF)-induced alterations in isolated Leydig cells (LCs). These NaF-induced alterations include decreased cell proliferation, steroidogenesis, and relative gene expression. Isolated LCs were incubated with NaF (0, 5, 20 mg/L) and/or 10 μg/ml VE, 100 ng/ml IGF-I, and 100 IU/ml hCG. NaF-treated cells' ability to secrete testosterone (T) was significantly less than other treated groups (P < 0.05). Additionally, in NaF-treated cells, there was a significant upregulation of certain relative mRNA expressions such as Star and Cyp11a, as well as significantly less cell proliferation in a dose-dependent manner (P < 0.05). These data clearly show that VE, IGF-1, and hCG have a protective effect in the LCs functions. Taken together, the final results of this study shown herein are consistent with the assumption that VE, IGF-I, and hCG volunteered ameliorative effects against the deleterious effects of NaF through their protective activity. Although it is hypothesized that ameliorative effects might have been involved, the fundamental pathway(s) remain(s) to be illuminated. Graphical Abstract ᅟ.
More Related Videos
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
04:14Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
Published on: October 6, 2023